<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: ABG Management Ltd. -->
          <cik>0001832106</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001861107</issuerCik>
        <issuerName>Ceribell, Inc.</issuerName>
        <issuerCusip>15678C102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>360 N. Pastoria Avenue</com:street1>
          <com:city>Sunnyvale</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94085</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ABG WTT-Ceribell Limited</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ABG V-Ceribell Limited</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>ABG V-Ceribell Limited is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Ally Bridge Group Global Life Science Capital Partners V, L.P.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Ally Bridge Group Global Life Science Capital Partners V, L.P. is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ABG Global Life Science Capital Partners V GP, L.P.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>ABG Global Life Science Capital Partners V GP, L.P. is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ABG Global Life Science Capital Partners V GP Limited</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>ABG Global Life Science Capital Partners V GP Limited is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ABG-WTT Global Life Science Capital Partners GP, L.P.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>ABG-WTT Global Life Science Capital Partners GP, L.P. is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ABG-WTT Global Life Science Capital Partners GP Limited</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>ABG-WTT Global Life Science Capital Partners GP Limited is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ABG Management Ltd.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>ABG Management Ltd. is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Ally Bridge Group (PE) LLC</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Ally Bridge Group (PE) LLC is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Fan Yu</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>O1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>2441267.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>2441267.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2441267.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.8</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Fan Yu is in a position to, directly or indirectly, exercise or share the ultimate voting and disposition control of the Common Stock owned by ABG WTT-Ceribell Limited.

The percentage of ownership based on 35,868,339 shares of Common Stock of the Issuer outstanding as of February 21, 2025, as reported on the Issuer's Form 10-K filed on February 25, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Ceribell, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>360 N. Pastoria Avenue, Sunnyvale, California 94085</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13G is jointly filed, pursuant to a Joint Filing Agreement attached hereto as Exhibit 1
ABG WTT-Ceribell Limited
ABG V-Ceribell Limited
Ally Bridge Group Global Life Science Capital Partners V, L.P.
ABG Global Life Science Capital Partners V GP, L.P.
ABG Global Life Science Capital Partners V GP Limited
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
ABG-WTT Global Life Science Capital Partners GP, L.P.
ABG-WTT Global Life Science Capital Partners GP Limited
ABG Management Ltd.
Ally Bridge Group (PE) LLC
Fan Yu</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>ABG WTT-Ceribell Limited
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG V-Ceribell Limited
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

Ally Bridge Group Global Life Science Capital Partners V, L.P
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG Global Life Science Capital Partners V GP, L.P.
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG Global Life Science Capital Partners V GP Limited
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG-WTT Global Life Science Capital Partners GP, L.P.
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG-WTT Global Life Science Capital Partners GP Limited
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

ABG Management Ltd.
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104

Ally Bridge Group (PE) LLC
430 Park Avenue
New York, New York 10022
United States of America

Fan Yu
c/o Maples Corporate Services Limited
Ugland House, Grand Cayman
Cayman Islands
KY1-1104</principalBusinessOfficeOrResidenceAddress>
        <citizenship>ABG WTT-Ceribell Limited - Cayman Islands
ABG V-Ceribell Limited - Cayman Islands
Ally Bridge Group Global Life Science Capital Partners V, L.P. - Cayman Islands
ABG Global Life Science Capital Partners V GP, L.P. - Cayman Islands
ABG Global Life Science Capital Partners V GP Limited - Cayman Islands
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. - Cayman Islands
ABG-WTT Global Life Science Capital Partners GP, L.P. - Cayman Islands
ABG-WTT Global Life Science Capital Partners GP Limited - Cayman Islands
ABG Management Ltd.- Cayman Islands
Ally Bridge Group (PE) LLC - Delaware
Fan Yu - Malta</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>ABG WTT-Ceribell Limited:  2,441,267
ABG V-Ceribell Limited:  2,441,267
Ally Bridge Group Global Life Science Capital Partners V, L.P.:  2,441,267
ABG Global Life Science Capital Partners V GP, L.P.:  2,441,267
ABG Global Life Science Capital Partners V GP Limited:  2,441,267
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.:  2,441,267
ABG-WTT Global Life Science Capital Partners GP, L.P.:   2,441,267
ABG-WTT Global Life Science Capital Partners GP Limited:   2,441,267
ABG Management Ltd.:   2,441,267
Ally Bridge Group (PE) LLC:   2,441,267
Fan Yu:   2,441,267</amountBeneficiallyOwned>
        <classPercent>ABG WTT-Ceribell Limited: 6.8%
ABG V-Ceribell Limited: 6.8%
Ally Bridge Group Global Life Science Capital Partners V, L.P. : 6.8%
ABG Global Life Science Capital Partners V GP, L.P. : 6.8%
ABG Global Life Science Capital Partners V GP Limited: 6.8%
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. : 6.8%
ABG-WTT Global Life Science Capital Partners GP, L.P.: 6.8%
ABG-WTT Global Life Science Capital Partners GP Limited: 6.8%
ABG Management Ltd.: 6.8%
Ally Bridge Group (PE) LLC: 6.8%
Fan Yu: 6.8%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>ABG WTT-Ceribell Limited: 0
ABG V-Ceribell Limited: 0
Ally Bridge Group Global Life Science Capital Partners V, L.P. : 0
ABG Global Life Science Capital Partners V GP, L.P. : 0
ABG Global Life Science Capital Partners V GP Limited: 0
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. : 0
ABG-WTT Global Life Science Capital Partners GP, L.P.: 0
ABG-WTT Global Life Science Capital Partners GP Limited: 0
ABG Management Ltd.: 0
Ally Bridge Group (PE) LLC: 0
Fan Yu: 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>ABG WTT-Ceribell Limited: 2,441,267
ABG V-Ceribell Limited:   2,441,267
Ally Bridge Group Global Life Science Capital Partners V, L.P.:   2,441,267
ABG Global Life Science Capital Partners V GP, L.P.:   2,441,267
ABG Global Life Science Capital Partners V GP Limited:   2,441,267
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. :   2,441,267
ABG-WTT Global Life Science Capital Partners GP, L.P.:   2,441,267
ABG-WTT Global Life Science Capital Partners GP Limited:   2,441,267
ABG Management Ltd.:   2,441,267
Ally Bridge Group (PE) LLC:   2,441,267
Fan Yu:   2,441,267</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>ABG WTT-Ceribell Limited: 0
ABG V-Ceribell Limited: 0
Ally Bridge Group Global Life Science Capital Partners V, L.P. : 0
ABG Global Life Science Capital Partners V GP, L.P. : 0
ABG Global Life Science Capital Partners V GP Limited: 0
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. : 0
ABG-WTT Global Life Science Capital Partners GP, L.P.: 0
ABG-WTT Global Life Science Capital Partners GP Limited: 0
ABG Management Ltd.: 0
Ally Bridge Group (PE) LLC: 0
Fan Yu: 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>ABG WTT-Ceribell Limited: 2,441,267
ABG V-Ceribell Limited:   2,441,267
Ally Bridge Group Global Life Science Capital Partners V, L.P.:   2,441,267
ABG Global Life Science Capital Partners V GP, L.P.:   2,441,267
ABG Global Life Science Capital Partners V GP Limited:   2,441,267
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. :   2,441,267
ABG-WTT Global Life Science Capital Partners GP, L.P.:   2,441,267
ABG-WTT Global Life Science Capital Partners GP Limited:   2,441,267
ABG Management Ltd.:   2,441,267
Ally Bridge Group (PE) LLC:   2,441,267
Fan Yu:   2,441,267</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <exhibitInfo>[Exhibit A - Joint Filing Agreement]</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>ABG WTT-Ceribell Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kevin Reilly</signature>
        <title>Kevin Reilly, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG V-Ceribell Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kevin Reilly</signature>
        <title>Kevin Reilly, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Ally Bridge Group Global Life Science Capital Partners V, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>By: ABG Global Life Science Capital Partners V GP, L.P., its general partner, By: ABG Global Life Science Capital Partners V GP Limited, its general p</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG Global Life Science Capital Partners V GP, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>By: ABG Global Life Science Capital Partners V GP Limited, its general partner, By: /s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG Global Life Science Capital Partners V GP Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>By: ABG-WTT Global Life Science Capital Partners GP, L.P., its general partner, By: ABG-WTT Global Life Science Capital Partners GP Limited, its gener</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG-WTT Global Life Science Capital Partners GP, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner, By: /s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG-WTT Global Life Science Capital Partners GP Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ABG Management Ltd.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Ally Bridge Group (PE) LLC</reportingPersonName>
      <signatureDetails>
        <signature>By: ABG Management Ltd., its managing member, By: /s/ Fan Yu</signature>
        <title>Fan Yu, Director</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Fan Yu</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Fan Yu</signature>
        <title>Fan Yu</title>
        <date>05/02/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
